
Kesimpta Coupons & Discount Card – Guaranteed Prices from $9300.69
My prescription
Edit
0.4ML of 20MG/0.4ML, Kesimpta (1 Pen)
Select pharmacy

Rite Aid
$9300.69
COUPON PRICE
Walgreens
$9694.26
COUPON PRICEKesimpta savings card
Show this card to your pharmacist
Rite Aid
$9300.69
BIN
ID
PCN
GRP
019876
LHC7F1A02B
CHIPPO
LHX
Powered by
Related monoclonal antibodies prescriptions
More prescriptions for multiple sclerosis
Related monoclonal antibodies prescriptions
More prescriptions for multiple sclerosis
Kesimpta dosage forms
Dosage | Quantity | Price from | Per unit |
---|---|---|---|
0.4ML of 20MG/0.4ML | 1 Pen | $9038.4 | $9038.4 |
Kesimpta Warnings
This document provides key safety information regarding the use of Kesimpta (ofatumumab). It is crucial to review the following points and discuss any concerns with your healthcare provider.
Increased Risk of Infections: Kesimpta (ofatumumab) may reduce your body's ability to combat infections, increasing the likelihood of bacterial, viral, or fungal infections. This risk is heightened if you are currently taking or have recently taken other medications that suppress the immune system. Additionally, Kesimpta (ofatumumab) can reactivate certain viruses, such as the hepatitis B virus (HBV), present in your body, which can be dangerous. If you develop an infection, your healthcare provider may advise discontinuing Kesimpta (ofatumumab) until the infection is resolved. This is particularly important for those with active or chronic infections, conditions that increase infection risk, or those on immunosuppressive drugs.
Injection Reactions: After taking Kesimpta (ofatumumab), you may experience reactions related to the injection, including fever, headache, muscle pain, chills, and fatigue. These reactions are more common within the first day of the initial dose but can occur with subsequent doses. To ensure your safety, your first injection should be administered in a hospital or clinic setting, where medical help is readily available in case of severe reactions.
Potential Harm to Unborn Babies: Animal studies suggest that Kesimpta (ofatumumab) may harm unborn babies; therefore, it is advised for females who are or could become pregnant to avoid using this medication. Use effective contraception during treatment and for at least six months following the last dose. If you are pregnant or planning to become pregnant, consult your healthcare provider to discuss safer alternatives for you and your baby.
Contraindications:
- Do not use Kesimpta (ofatumumab) if you have an active hepatitis B infection, as this medication may pose serious health risks in such cases. Always speak to your healthcare provider if you have any concerns or questions regarding its use.
Kesimpta Side Effects
When using this medication, some individuals may experience common side effects, which are generally mild and include redness, swelling, itching, or pain at the injection site. You might also notice fever, headaches, muscle aches, chills, and general tiredness. These reactions often become milder with subsequent doses. If they persist or worsen, it is important to consult your healthcare provider. Sore throat, runny nose, and symptoms akin to respiratory tract infections can occur, as well as urinary tract infection symptoms like pain while urinating.
In rare instances, this medication can lead to more severe side effects. It may suppress your immune system, increasing the risk of serious infections characterized by a persistent sore throat, fever, chills, or cough. Additionally, it can cause liver disease, particularly for those with a history of hepatitis B, potentially leading to nausea, vomiting, loss of appetite, stomach pain, jaundice, or dark urine. There is also a rare risk of developing progressive multifocal leukoencephalopathy (PML), a serious brain infection. Symptoms include clumsiness, loss of coordination, confusion, memory loss, difficulty talking, seizures, and vision changes.
Severe allergic reactions are very rare but serious. Seek immediate medical assistance if you experience symptoms like a rash, swelling of the face or throat, severe dizziness, or trouble breathing. If you notice other side effects not mentioned here, contact your healthcare provider.
Kesimpta Interactions
What is Kesimpta medicine used for?
Kesimpta is used for the treatment of relapsing forms of multiple sclerosis (MS) in adults. This includes clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
How many years can you stay on Kesimpta?
The duration a patient can stay on Kesimpta (ofatumumab) is determined by their healthcare provider based on the individual's response to the treatment and any side effects experienced. There is no specific maximum duration established, and treatment can continue as long as it remains effective and the patient tolerates it well. Regular monitoring and consultations with a healthcare provider are essential to assess the ongoing suitability of the medication.
How much does Kesimpta cost per year?
The cost of Kesimpta can vary based on factors such as insurance coverage, location, and pharmacy. Without insurance, the list price for Kesimpta is approximately $6,900 per month, which totals around $82,800 annually. However, patients are encouraged to check with their insurance provider and explore patient assistance programs that may significantly reduce out-of-pocket expenses.
Which is better, Kesimpta or Ocrevus?
The choice between Kesimpta and Ocrevus depends on various factors, including the specific medical condition being treated, the patient's health profile, and their response to previous treatments. Both medications are used to treat multiple sclerosis, but they have different administration methods and dosing schedules. Kesimpta is administered as a subcutaneous injection, while Ocrevus is given as an intravenous infusion. The decision on which medication is better should be made by a healthcare provider, who can consider the patient's individual needs and preferences.
How many years can you stay on KESIMPTA?
The duration a patient can stay on Kesimpta (ofatumumab) is determined by their healthcare provider based on the individual's response to the treatment and any side effects experienced. There is no specific maximum duration for using Kesimpta, and it can be continued as long as it remains effective and well-tolerated. Regular monitoring and consultations with a healthcare provider are essential to assess the ongoing suitability of the treatment.